Search

Your search keyword '"Snyder, Lawrence B."' showing total 114 results

Search Constraints

Start Over You searched for: Author "Snyder, Lawrence B." Remove constraint Author: "Snyder, Lawrence B."
114 results on '"Snyder, Lawrence B."'

Search Results

2. Characterizations of HCV NS5A replication complex inhibitors

3. Abstract 44: The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC for the treatment of patients with breast cancer

4. Abstract 43: Discovery of ARV-110, a first in class androgen receptor degrading PROTAC for the treatment of men with metastatic castration resistant prostate cancer

6. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

7. Chapter 22. Non-HIV antiviral agents

8. Alicyclic Isoxazolinone Antibacterial Agents

9. Total synthesis of Baccatin III and taxol

11. ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.

12. Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box

13. Abstract 5236: ARV-110: An androgen receptor PROTAC degrader for prostate cancer

14. An oral androgen receptor PROTAC degrader for prostate cancer.

15. Abstract 5637: An oral Androgen Receptor PROTAC degrader for prostate cancer

16. An oral androgen receptor PROTAC degrader for prostate cancer.

18. HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies

19. Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5

20. HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamides

22. Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir

23. Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons

24. HCV NS5A Replication Complex Inhibitors. Part 4.1 Optimization for Genotype 1a Replicon Inhibitory Activity

25. The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization

26. Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures

27. Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

28. Identification of Hepatitis C Virus NS5A Inhibitors

31. Biaryl isoxazolinone antibacterial agents

37. Hepatitis C Virus NS5A ReplicationComplex Inhibitors.Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotypewith Inhibitory Activity Toward Genotypes 1a and 1b Replicons.

39. A Total Synthesis of Taxol

40. Eine Totalsynthese von Taxol

43. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.

45. Hepatitis C Virus Inhibitors

46. Hepatitis C Virus Inhibitors

47. Hepatitis C Virus Inhibitors

48. Hepatitis C Virus Inhibitors

50. Hepatitis C Virus Inhibitors

Catalog

Books, media, physical & digital resources